presents

Medicenna Presents Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

November 08, 2024 10:00 ET | Source: Medicenna Therapeutics Corp.    MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” BiSKIT…

1 month ago

MUSEUM OF ISLAMIC ART PRESENTS LANDMARK EXHIBITION SURVEYING THE ISLAMIC ARTISTIC TRADITIONS OF MOROCCO

DOHA, Qatar, Nov. 5, 2024 /PRNewswire/ --The Museum of Islamic Art (MIA) unveiled Splendours of the Atlas: A Voyage Through…

2 months ago

Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) --  Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology…

2 months ago

MUSEUM OF ISLAMIC ART PRESENTS LANDMARK EXHIBITION SURVEYING THE ISLAMIC ARTISTIC TRADITIONS OF MOROCCO

DOHA, Qatar, Nov. 5, 2024 /PRNewswire/ --The Museum of Islamic Art (MIA) unveiled Splendours of the Atlas: A Voyage Through…

2 months ago
Show previous Posts